Combined use of presepsin and (1,3)-d-glucan as biomarkers for diagnosing candida sepsis and monitoring the effectiveness of treatment in critically ill patients

HIGHLIGHTS

• who: Radim Dobiáš and collaborators from the Department of Bacteriology and Mycology, Public Health Institute in, , RepublicInstitute of Laboratory Medicine, Faculty of Medicine, University of, , have published the paper: Combined Use of Presepsin and (1,3)-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients, in the Journal: (JOURNAL)
• what: The authors propose proposethat thatserum serum BDG measurements acquired within 3 days IBC
• how: The results are consistent with these reports.
• future: Studies are needed to determine whether this could significantly impact . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.